[Hiring] DMPK Scientist @Arvinas

Role Description

We have an exciting opening for an experienced DMPK scientist. The incumbent will contribute as a DMPK scientist on project teams from drug discovery through all stages of drug development, with a scientific background on key aspects of DMPK science, including but not limited to:

• In vitro and in vivo ADME
• Animal PK
• Toxicokinetics
• Drug metabolism
• DME- and transporter-based DDI
• 14C-ADME studies
• QWBA
• Human PK prediction

This position reports to the Head of Nonclinical Sciences and may be based at our headquarter location in New Haven, CT or a remote role based within the U.S.

Principal Responsibilities

• Serve as a project DMPK scientist and advise discovery teams on strategies for early ADMET profiling up to the selection of lead candidate into preclinical development.
• Represent DMPK function on company-wide development teams to support the advancement of preclinical and clinical development assets.
• Contribute to the in vitro DDI and other in vitro/in vivo DMPK assessment for individual preclinical drug candidates and ensure timely availability of key data as part of the IND enabling activities.
• Recommend stage appropriate clinical DDI strategy to the clinical pharmacology function.
• Contribute to outsource of DMPK studies and ensure timely and high quality conduct of in vitro and in vivo ADMET studies.
• Partner with key CROs to develop and customize ADMET assays to support PROTAC drug discovery and development.
• Contribute to the preparation of DMPK component of regulatory documents such as IND, IB, or other documents.
• Stay up to date with the scientific advance and regulatory landscape for DMPK science in drug discovery and development.

Qualifications

• In-depth knowledge or expertise on one or several aspects of DMPK science in drug discovery and/or development, such as biotransformation, bioanalysis, pharmacokinetics, toxicokinetics, DME- and transporter-based drug-drug interaction, PBPK or PK/PD modeling, human PK prediction.
• General knowledge of drug discovery and development process.
• Experience in representing DMPK function on discovery and development teams.
• Ability to integrate DMPK knowledge of individual drugs and prepare DMPK components of regulatory documents.
• Hands-on experience and proficiency in PK analysis with PK or modeling software such as Phoenix.
• Knowledge of relevant regulatory guidance in areas such as drug-drug interaction, bioanalysis, and GLP.

Requirements

• Ph.D. in pharmaceutical science, chemistry, biochemistry, or related scientific discipline with ten-plus years of relevant experience in DMPK in the biopharmaceutical industry or CROs supporting pharmaceutical development, preferably with a focus on small molecules.
• Direct experience with PROTAC, molecular glue, or ADC highly desirable.
• Arvinas will not be providing VISA sponsorship for this position. You must have the ability to work without a need for a current or future VISA sponsorship.
• The duties of this role are generally conducted in a combination of lab and home office environments.
• Employees must be able, with or without an accommodation to lift/carry 15/30 pounds unassisted/assisted; work comfortably in a controlled environment with and around biological, infectious and hazardous materials; gown/degown PPE; use a computer; engage in communications via phone, video, and electronic messaging; engage in problem solving, analysis and dialogue; collaborate with others; maintain general availability during standard business hours.

Benefits

• Competitive package of base and incentive compensation.
• Comprehensive benefits program designed to support the health, wellness and financial security of employees and their families.
• Group medical, vision and dental coverage.
• Group and supplemental life insurance.
• And much more.

Company Description

Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins.

For more information about Arvinas, please visit www.arvinas.com and connect on LinkedIn and X .